These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6868058)

  • 1. Complete heart block--another HLA B27 associated disease manifestation.
    Bergfeldt L; Möller E
    Tissue Antigens; 1983 May; 21(5):385-90. PubMed ID: 6868058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pacemaker treated women with heart block have no increase in the frequency of HLA-B27 and associated rheumatic disorders in contrast to men--a sex linked difference in disease susceptibility.
    Bergfeldt L; Möller E
    J Rheumatol; 1986 Oct; 13(5):941-3. PubMed ID: 3493346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart conduction disturbance: an HLA-B27 associated disease.
    Peeters AJ; ten Wolde S; Sedney MI; de Vries RR; Dijkmans BA
    Ann Rheum Dis; 1991 Jun; 50(6):348-50. PubMed ID: 2059077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete heart block in HLA B27 associated disease. Electrophysiological and clinical characteristics.
    Bergfeldt L; Vallin H; Edhag O
    Br Heart J; 1984 Feb; 51(2):184-8. PubMed ID: 6607060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA B27-associated rheumatic diseases with severe cardiac bradyarrhythmias. Clinical features and prevalence in 223 men with permanent pacemakers.
    Bergfeldt L
    Am J Med; 1983 Aug; 75(2):210-5. PubMed ID: 6603791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality in pacemaker-treated patients. A follow-up study of the impact of HLA B27 and associated rheumatic disorders.
    Bergfeldt L; Allebeck P; Edhag O
    Acta Med Scand; 1987; 222(4):293-9. PubMed ID: 3501228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased frequency of HLA-Bw62 and Bw35 CREG antigens in HLA-B27 negative ankylosing spondylitis.
    Wagener P; Zeidler H; Eckert G; Deicher H
    Z Rheumatol; 1984; 43(5):253-7. PubMed ID: 6335328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA phenotypes in patients with rheumatic fever, rheumatic heart disease, and Yersinia arthritis.
    Leirisalo M; Laitinen O; Tiilikainen A
    J Rheumatol Suppl; 1977; 3():78-83. PubMed ID: 266605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two distinctive HLA haplotypes harbor the B27 alleles negatively or positively associated with ankylosing spondylitis in Sardinia: implications for disease pathogenesis.
    Fiorillo MT; Cauli A; Carcassi C; Bitti PP; Vacca A; Passiu G; Bettosini F; Mathieu A; Sorrentino R
    Arthritis Rheum; 2003 May; 48(5):1385-9. PubMed ID: 12746911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA B27 and the genetics of ankylosing spondylitis.
    Woodrow JC; Eastmond CJ
    Ann Rheum Dis; 1978 Dec; 37(6):504-9. PubMed ID: 107868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Third-degree heart block developing in an HLA-B27-positive individual with a family history of ankylosing spondylitis.
    Sahi SP; Winfield CR
    Br J Clin Pract; 1990 Dec; 44(12):794-5. PubMed ID: 2102255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic differences between B27 positive patients with ankylosing spondylitis and B27 positive healthy controls.
    Calin A; Marder A; Becks E; Burns T
    Arthritis Rheum; 1983 Dec; 26(12):1460-4. PubMed ID: 6606431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-B27: an important genetic risk factor for lone aortic regurgitation and severe conduction system abnormalities.
    Bergfeldt L; Insulander P; Lindblom D; Möller E; Edhag O
    Am J Med; 1988 Jul; 85(1):12-8. PubMed ID: 3260450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ankylosing spondylitis (Bechterew) and tissue antigen HLA-B 27. I. Diagnostic value of HLA-typing].
    Gerber N; Ambrosini GC; Böni A; Ossola A; Wagenhäuser FJ; Fehr K; von Felten A
    Z Rheumatol; 1977; 36(7-8):219-23. PubMed ID: 919797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet aggregating activity in serum from patients with HLA-B27 associated rheumatic and cardiac disorders: a possible link to the proliferative vascular changes.
    Bergfeldt L; Edhag O; Holm G; Norberg R
    Br Heart J; 1991 Apr; 65(4):184-7. PubMed ID: 2029440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cross-reacting HLA-B alleles as genetic markers of HLA-B27 negative ankylosing spondylitis].
    Haberhauer G; Bröll H
    Z Rheumatol; 1986; 45(5):260-2. PubMed ID: 3492838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic survey of the HLA B27 prevalence in inflammatory rheumatic diseases.
    Dequeker J; Decock T; Walravens M; Van de Putte I
    J Rheumatol; 1978; 5(4):452-9. PubMed ID: 739494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunogenetic study of the HLA system in families of patients with ankylosing spondylitis].
    Grubić Z; Kerhin-Brkljacić V; Cecuk-Jelicić E; Kastelan A
    Reumatizam; 2000; 47(1):13-9. PubMed ID: 11552604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA B27 and ankylosing spondylitis: a population and family study in Sardinia.
    Contu L; Capelli P; Sale S
    J Rheumatol Suppl; 1977; 3():18-23. PubMed ID: 266592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased level of HLA-B27 expression in ankylosing spondylitis patients compared with healthy HLA-B27-positive subjects: a possible further susceptibility factor for the development of disease.
    Cauli A; Dessole G; Fiorillo MT; Vacca A; Mameli A; Bitti P; Passiu G; Sorrentino R; Mathieu A
    Rheumatology (Oxford); 2002 Dec; 41(12):1375-9. PubMed ID: 12468816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.